Wim Van Biesen
A5052077932- Dialysis and Renal Disease Management
- Acute Kidney Injury Research
- Central Venous Catheters and Hemodialysis
- Chronic Kidney Disease and Diabetes
- Muscle and Compartmental Disorders
- Health Systems, Economic Evaluations, Quality of Life
- Electrolyte and hormonal disorders
- Renal function and acid-base balance
- Renal Transplantation Outcomes and Treatments
- Trauma, Hemostasis, Coagulopathy, Resuscitation
- Organ Donation and Transplantation
- Neurological and metabolic disorders
- Healthcare cost, quality, practices
- Erythropoietin and Anemia Treatment
- Diet and metabolism studies
- Parathyroid Disorders and Treatments
- Sepsis Diagnosis and Treatment
- Pharmacological Effects and Toxicity Studies
- Renal and Vascular Pathologies
- Patient Satisfaction in Healthcare
- Metabolism and Genetic Disorders
- Hospital Admissions and Outcomes
- Iron Metabolism and Disorders
- Magnesium in Health and Disease
- Blood Pressure and Hypertension Studies
Ghent University Hospital
2016-2025
Ghent University
2001-2024
Universitair Ziekenhuis Brussel
2012-2023
Klinikum rechts der Isar
2023
Technical University of Munich
2023
Renal Association
2001-2018
RELX Group (United States)
2017-2018
European Renal Association – European Dialysis and Transplant Association
2018
Indiana University School of Medicine
2016
Medical University of Vienna
2016
Hyponatraemia, defined as a serum sodium concentration <135 mmol/l, is the most common disorder of body fluid and electrolyte balance encountered in clinical practice. It can lead to wide spectrum symptoms, from subtle severe or even life threatening, associated with increased mortality, morbidity length hospital stay patients presenting range conditions. Despite this, management remains problematic. The prevalence hyponatraemia widely different conditions fact that managed by clinicians...
The broad clinical syndrome of acute kidney injury (AKI) encompasses various aetiologies, including specific diseases (e.g. interstitial nephritis), non-specific conditions renal ischaemia) as well extrarenal pathology post-renal obstruction). AKI is a serious condition that affects structure and function acutely, but also in the long term. Recent epidemiological evidence supports notion even mild, reversible conveys risk persistent tissue damage, severe can be accompanied by an irreversible...
Hyponatraemia, defined as a serum sodium concentration <135 mmol/l, is the most common disorder of body fluid and electrolyte balance encountered in clinical practice. It can lead to wide spectrum symptoms, from subtle severe or even life threatening, associated with increased mortality, morbidity length hospital stay patients presenting range conditions. Despite this, management remains problematic. The prevalence hyponatraemia widely different conditions fact that managed by clinicians...
Recently, the Kidney Disease: Improving Global Outcomes (KDIGO) group has produced comprehensive clinical practice guidelines for management of anaemia in CKD patients. These addressed all important points related to patients, including therapy with erythropoieis stimulating agents (ESA), iron therapy, ESA resistance and blood transfusion use. Because most were ‘soft’ rather than ‘strong’, because global need be adapted implemented into regional context where they are used, on behalf...
Hypoparathyroidism (HypoPT) is a rare (orphan) endocrine disease with low calcium and inappropriately (insufficient) circulating parathyroid hormone levels, most often in adults secondary to thyroid surgery. Standard treatment activated vitamin D analogues supplementation not replacement of the lacking hormone, as other hormonal deficiency states. The purpose this guideline provide clinicians guidance on monitoring chronic HypoPT who do have end-stage renal disease. We intend draft practical...
The European Best Practice Guideline group (EBPG) issued guidelines on the evaluation and selection of kidney donor transplant candidates, as well post-transplant recipient care, in year 2000 2002. new Renal board decided 2009 that these needed updating. In order to avoid duplication efforts with disease improving global outcomes, which published clinical practice care recipients, we did not address issues present guidelines. guideline was developed following a rigorous methodological...
Background Euvolemia is an important adequacy parameter in peritoneal dialysis (PD) patients. However, accurate tools to evaluate volume status clinical practice and data on PD patients as compared healthy population, the associated factors, have not been available so far. Methods We used a bio-impedance spectroscopy device, Body Composition Monitor (BCM) assess cross-sectional cohort of prevalent different European countries. The results were age gender matched population. Results Only 40%...
Chronic kidney disease (CKD) is characterized by accumulation of protein-bound uremic toxins such as p-cresyl sulfate, glucuronide, indoxyl sulfate and indole-3-acetic acid, which originate in the gut. Intestinal bacteria metabolize aromatic amino acids into p-cresol indole, (further conjugated colon mucosa liver) acid. Here we measured fecal, plasma urine metabolite concentrations; contribution gut bacterial generation to accumulation; influx circulating at different stages CKD. Feces,...
The global nephrology community recognizes the need for a cohesive strategy to address growing problem of end-stage kidney disease (ESKD). In March 2018, International Society Nephrology hosted summit on integrated ESKD care, including 92 individuals from around globe with diverse expertise and professional backgrounds. attendees were 41 countries, 16 participants 11 low- lower-middle-income countries. purpose was develop strategic plan improve worldwide access by identifying prioritizing...
Studies analyzing the outcome of integrative care end-stage renal disease (ESRD) patients, whereby patients are transferred from one replacement modality to another according individual needs, scant. In this study, we analyzed 417 files 223 hemodialysis (HD) and 194 peritoneal dialysis (PD) starting therapy between 1979 1996, evaluate effect such an approach. Analysis was done for survival on their first modality, intention-to-treat (counting total time therapy, but with exclusion...